Kazuo Watanabe

Years Active: 2020-2023
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Shuichi Mitsunaga, Masafumi Ikeda, Hiroshi Imaoka, Mitsuhito Sasaki, Kazuo Watanabe, Akihiro Sato, Kazunori Aoki, Atsushi Ochiai, Mayu Makikawa, Masanobu Nishidate, Kyoko Yamaguchi, Kimio Terao, Noriaki Sawada, Takashi Fujitomo, Etsuko Fujii, Atsuhiko Kato, Hiroyuki Tsunoda
Fibroblast inhibition by tocilizumab enabled gemcitabine/nab-paclitaxel rechallenge for pancreatic cancer. Cancer science (2023)
Kazuo Watanabe, Shuichi Mitsunaga, Motohiro Kojima, Hidetaka Suzuki, Ai Irisawa, Hideaki Takahashi, Mitsuhito Sasaki, Yusuke Hashimoto, Hiroshi Imaoka, Izumi Ohno, Masafumi Ikeda, Tetsuo Akimoto, Atsushi Ochiai
The "histological replacement growth pattern" represents aggressive invasive behavior in liver metastasis from pancreatic cancer. Cancer medicine 9 (9) (2020)

Kazuo Watanabe.css-eqlu8i{font-size:small;padding-left:4px;}